balanced

Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results

...ing. Although the advantages of rapid TAT must be balanced with the need for stringent quality control (QC), many POC analyzers have internal QC systems, and manufacturers provide external controls appropriate to each assay. Biosite Inc., Response Biomedical Corp., and Roche Diagnostic Systems have FDA appro...

Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology

...ellectual property portfolio, theCompany applies a balanced risk business model to the developmentof its Antic...d favorable tissuepenetration of Anticalins can be balanced through adjustablemodulation of serum half-life. Pieris and its collaborators are not only able to ...

Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo

...ted Professional Sleep Societies (APSS),VEC-162, a balanced melatonin (MT1/MT2) receptor agonist beingdeveloped by Vanda Pharmaceuticals Inc. , demonstrated improvementsin objective and subjective measures of sleep onset and maintenancein a Phase III trial of transient insomnia. VEC-162 was assessed in a ran...

Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the Annual Meeting of the Associated Professional Sleep Societies

...ase III clinicaltrial results for VEC-162, Vanda's balanced melatonin (MT1/MT2)receptor agonist, at SLEEP 2007, the 21st annual meeting of theAssociated Professional Sleep Societies, (APSS). The Vanda presentation will take place at the Convention Centerin Minneapolis, MN on June 13 from 4:00pm - 4:15pm CDT,...

Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared to Chemotherapy Alone for Sarcoma Cancer Patients

...rmia therapy. The patient characteristicswere well balanced between these two groups. Their treatments wereadministered in 4 cycles every 3 weeks before and after surgery andradiation therapy. For patients who received both hyperthermiatherapy and chemotherapy the median disease free survival was 31.7months, ...

Antipsychotic Iloperidone Results Show Favorable Akathisia Profile

...rial experiencewith iloperidone suggests that this balanced antagonism may provideefficacy against positive and negative symptoms of schizophrenia,while causing reduced EPS and hyperprolactinemia relative to otheravailable atypical antipsychotics. Iloperidone also appears to havea favorable weight and metabol...

Alnylam Reports Results of Human Experimental Infection Model with Respiratory Syncytial Virus

... represents an importantcomponent of the company's balanced pipeline of proprietary andpartnered RNAi therapeutics programs. Phase II Experimental Infection Study Details Alnylam will be conducting a randomized, placebo-controlled,double-blind Phase II experimental infection study to assess thesafety and to...

Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis

.... Forty patients completed the study. Groups were balanced atbaseline except for greater T1-enhancing lesion number in theCOPAXONE(R) plus minocycline group (median 3 versus 2; mean 7.62versus 2.43 (p=0.07)). Despite this imbalance, treatment trendedtoward significance in the COPAXONE(R) plus minocycline gro...

Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis

.... Forty patients completed the study. Groups were balanced atbaseline except for greater T1-enhancing lesion number in theCOPAXONE(r) plus minocycline group (median 3 versus 2; mean 7.62versus 2.43 (p=0.07)). Despite this imbalance, treatment trendedtoward significance in the COPAXONE(r) plus minocycline gro...

Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of Tysabri in Patients with Multiple Sclerosis

... theoverall incidence and rate of infections, were balanced betweentreatment groups. Herpes infections were slightly more common inpatients treated with TYSABRI. Serious opportunistic and otheratypical infections have been observed in TYSABRI-treated patients,some of whom were receiving concurrent immunosuppr...

Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's Conference

... that we have implemented a soundand strategically balanced clinical plan for our compounds and weanticipate the results eagerly." "Data published in The Journal of Molecular Neuroscience showsthat AL-108 can modify disease progression in one of the mostrelevant models of Alzheimer's disease and our clinic...

Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific Anticalin in Preclinical Studies

...ellectual property portfolio, the Companyapplies a balanced risk business model to the development of itsAntic...avorabletissue penetration of Anticalins(R) can be balanced throughadjustable modulation of serum half-life and valency by establishedmethodologies. By develop...

Nutra Pharma Announces Publication of Research on Treatment for Multiple Sclerosis

...nces. CriticalReviews(TM) in Immunology presents a balanced overview ofcontemporary immunology and melds together molecular immunology andimmunobiology. The Journal is published six times each year. http://www.begellhouse.com/journals/2ff21abf44b19838.html About Nutra Pharma Corp. Nutra Pharma Corp. is a b...